๐Ÿฉบ ANTITHROMBOTIC AGENTS ๐Ÿท๏ธ Fibrinolytic
๐Ÿ‘จโ€โš•๏ธ Clinically Reviewed by: PakistaniBano Medical Editorial Board (Pharm.D Panel)
๐Ÿ“… Reviewed: November 2026 โ€ข ๐Ÿ” Authority: DRAP / WHO ATC
๐Ÿ“ฆ Formulations, Pack Sizes & Retail Prices Currency: Rs.
Dosage Form Reg. No Pack Size Trade Price (TP) Maximum Retail Price (MRP)
Inj 1.5 MIU 028483 1 Vial Rs.3910.00 Rs.4600.00

๐Ÿ“‹ Indications & Clinical Dosage

*Acute myocardial infarction:* Adult: 1 500 000 units, dose to be given over 60 minutes,within 12 hours of onset of symptom. *Deep-vein thrombosis, Pulmonary embolism, Acute arterial thromboembolism, Central retinal venous or arterial thrombosis:* Adult: 250 000 units, dose to be given over 30 minutes, then 100 000 units every 1 hour for up to 12-72 hours, according to condition with monitoring of clotting parameters (consult product literature) *Acute pulmonary embolism:* Adult: 3 million unit dose over 24 hr.

๐Ÿ’Š Mode of Administration

For IV infusion, give continuously or intermittently;reconstitute with sodium chloride 0.9%, then dilutefurther with Glucose 5% or Sodium Chloride 0.9% after reconstitution. Do not administer by IM injection, for IV or infra-coronary use only. Infusion pump is required. Use in-line filter >0.8 micron. CANNULA OCCLUSION: 250000 units into cannula, clamp for 2 hours then aspirate contents and flushwith NS.

โ›” Contraindications

Allergy and cross-sensitivity; Contra-indicated if previous allergic reaction to streptokinase, recent streptokinasetherapy (5 days streptokinasepreviously), severe liver or kidney damage, recent haemorrhage, haemorrhagic diathesis, severe hypotension, streptococcal infections, sub-acute bacterial endocarditis, recent surgery, bleeding tendencies.

โš ๏ธ Precautions & Warnings

Obtain haemostatic status of patient before starting therapy. Followup with anticoagulant therapy. Seeliterature.

๐Ÿ”„ Drug Interactions

Anticoagulants, drugs affecting platelet function.

โš ๏ธ Adverse Reactions / Side Effects

Hypotension, arrhythmias, Febrile reactions. Rare; Guillain-Barrsyndrome, anaphylaxis Haemorrhage.

๐Ÿคฐ Pregnancy & Lactation Safety

Pregnancy Risk:
Contraindicated in pregnancy.
Lactation / Breastfeeding:
Caution advised or effect undetermined

๐Ÿงช Compatibility & Storage Stability

Compatibility: Stable in D5W, NS. Incompatible with dextrans

Stability & Storage: Intact vials should be stored at room temperature stability ofparenteral admixture at roomtemperature (25C) is 8 hours and atrefrigeration (4C) is 24 hours. Reconstituted solutions should berefrigerated.

๐Ÿ“š Official Regulatory & Clinical References

  • Drug Regulatory Authority of Pakistan (DRAP): Drug Registration, S.R.O. Price Gazettes & National Essential Medicines List (NEML).
  • World Health Organization (WHO): Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index).
  • Formulary Standards: British National Formulary (BNF) & Pakistan National Formulary (PNF) guidelines.

Related Medicines

Medicines related to this brand, grouped by relevance.

Same generic: STREPTOKINASE

AKINASE
AKHAI
Rs.464832
DICLAIR-ST
GENE-TECH
Rs.4900.00
DURAKINASE
MEDISURE
Rs.4388.00
STREPTASE
HAKIMSONS
Rs.5765.00
STREPTOKINASE
HAJI MEDICINE
Rs.7966.00
UNITINASE
HIGHNOON
Rs.4370.00

More from MEDINET

Rs.610.00
BIOYETIN
MEDINET
Rs.6500.00
CPT 11
MEDINET
Rs.7607.25

Same category: ANTITHROMBOTIC AGENTS

Rs.36200.00
CLEXANE
SANOFI-AVENTIS
Rs.410.00 Inj 40 mg(017004)

โšก Quick Actions

๐Ÿ’ฌ Share via WhatsApp